First things first. They are going to need lots of money to do the Phase 2, and thenPhase 3 studies. Hundreds of millions. So either debt or equity offering or some kind of collaboration with big pharma, which would be smart. This company, with no revenue and $8 M in cash cannot do it by itself.$Neurosense Therapeutics Ltd(NRSN)$
精彩评论